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Abstract
Background: Alexander disease (ALX) is a rare neurological disorder characterized by white matter degeneration
and cytoplasmic inclusions in astrocytes called Rosenthal fibers, labeled by antibodies against glial fibrillary acidic
protein (GFAP). Three subtypes are distinguished according to age at onset: infantile (under age 2), juvenile (age
2 to 12) and adult (over age 12). Following the identification of heterozygous mutations in GFAP that cause this
disease, cases of adult-onset ALX have been increasingly reported.
Case Presentation: We present a 60-year-old Japanese man with an unremarkable past and no family history of
ALX. After head trauma in a traffic accident at the age of 46, his character changed, and dementia and dysarthria
developed, but he remained independent. Spastic paresis and dysphagia were observed at age 57 and 59,
respectively, and worsened progressively. Neurological examination at the age of 60 revealed dementia,
pseudobulbar palsy, left-side predominant spastic tetraparesis, axial rigidity, bradykinesia and gaze-evoked
nystagmus. Brain MRI showed tadpole-like atrophy of the brainstem, caused by marked atrophy of the medulla
oblongata, cervical spinal cord and midbrain tegmentum, with an intact pontine base. Analysis of the GFAP gene
revealed a heterozygous missense mutation, c.827G>T, p.R276L, which was already shown to be pathogenic in a
case of pathologically proven hereditary adult-onset ALX.
Conclusion: The typical tadpole-like appearance of the brainstem is strongly suggestive of adult-onset ALX, and
should lead to a genetic investigation of the GFAP gene. The unusual feature of this patient is the symmetrical
involvement of the basal ganglia, which is rarely observed in the adult form of the disease. More patients must be
examined to confirm, clinically and neuroradiologically, extrapyramidal involvement of the basal ganglia in adult-
onset ALX.
Background
Alexander disease (ALX) (OMIM #203450), originally
described by Alexander in 1949 [1], is a rare and fatal
disease of the central nervous system caused by astro-
cyte dysfunction [2,3]. The pathological hallmark of the
disease is the accumulation of ubiquitinated intracyto-
plasmic inclusions in astrocytes, called Rosenthal fibers,
which are composed of glial fibrillary acidic protein
(GFAP), the main intermediate filament of astrocytes, in
association with the small heat shock proteins, HSP27
and aB-crystallin [4].
The clinical features of typical infantile-onset ALX,
with onset before the age of two, include megalence-
phaly, seizures, spastic paresis and psychomotor dete-
rioration with leukoencephalopathy characterized by
white matter abnormalities predominating in the frontal
lobes. As cases accumulate, however, atypical patients
have also been described. Adult-onset ALX, with onset
over the age of 12, is characterized by more slowly pro-
gressive bulbar or pseudobulbar palsy, spastic paresis,
ataxia, palatal myoclonus and essentially normal psychic
and intellectual functions. Juvenile-onset ALX, with
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onset between age 2 and 12, bridges the gap between
infantile and adult forms of the disease. However, it is
not yet clear whether these three categories are the
same disease. The clinical presentations are diverse; the
only common feature is the presence of pathologically
proven Rosenthal fibers [5,6].
Owing to the discovery of inclusion bodies indistin-
guishable from Rosenthal fibers in fatal GFAP transgenic
mice overexpressing human GFAP in astrocytes [7],
de novo heterozygous mutations in the gene encoding
GFAP, the main component of Rosenthal fibers, have
been identified in patients with the infantile form of
ALX [8]. GFAP gene mutations have also been identified
in the juvenile [8,9] and adult [10,11] forms. These three
clinically diverse forms are now widely accepted to be
part of the same spectrum [12].
Each subtype has characteristic MRI findings. Cerebral
white matter abnormalities, predominating in the frontal
lobes, are typical of the infantile form of ALX [13],
whereas nodular brainstem lesions and a kind of “garland”
along the ventricular wall are seen, with contrast enhance-
ment, in the juvenile form [14,15]. The adult form has a
unique tadpole-like feature, caused by marked atrophy of
the medulla oblongata and cervical spinal cord with an
intact pontine base [11].
Here we present a case of sporadic adult-onset ALX
with specific MRI findings: a typical tadpole-like brain-
stem, but also symmetric involvement of the basal gang-
lia, which is unusual in the adult form of ALX.
Case Presentation
This Japanese patient, with an unremarkable past and no
family history had been healthy until he was involved in a
traffic accident at the age of 46. He suffered a bilateral
brain contusion in the fronto-orbital areas, predomina-
ting on the left side. He did not lose his consciousness,
but retrograde amnesia was seen. There was no hypoxia.
After this accident, his character changed. He became
querellous, could no longer manage his shop, and soon
retired. He gradually became taciturn and his pronuncia-
tion became unclear, but he remained independent. At
age 57, he began to drag his left foot as he walked, and
this symptom gradually worsened. At the age of 59, pro-
gressive dysphagia appeared. He was referred to our hos-
pital at the age of 60. Neurological examination revealed
pseudobulbar palsy including aphonia, emotional inconti-
nence and dysphagia, left-side predominant tetraparesis.
The tone of the limb muscles was spastic, with bilateral
positive Babinski signs. Axial rigidity, bradykinesia and
retropulsion were observed, but no tremor or palatal
myoclonus. Cerebellar ataxia was ambiguous because of
spastic tetraparesis requiring use of a wheelchair, but
bilateral gaze-evoked nystagmus was seen. He was clearly
demented and angrily refused everything he was asked to
do by shaking his head instead of speaking because of
aphonia. Further evaluation of his dementia was
impossible.
Laboratory tests, including hematology, routine blood
chemistry, and analyses of urine and cerebrospinal fluid,
were unremarkable. In addition to the bilateral contu-
sion in the fronto-orbital areas, especially on the left
side, brain MRI showed a tadpole-like brainstem, caused
by marked atrophy from the medulla oblongata to the
cervical spinal cord, sparing the pontine base. Marked
atrophy of the midbrain tegmentum, mild cerebellar
atrophy with a little enlargement of the fourth ventricle,
and slight cerebral atrophy were also seen. The typical
periventricular lesions (ventricular garlands [15]) and
leukoencephalopathy were not seen, however, several
lacunae were observed bilaterally in deep white matter.
The posterior part of globus pallidus was involved bilat-
erally, as shown by a signal change without contrast
enhancement (Figure 1).
With informed consent, the GFAP gene was
sequenced, and a heterogeneous missense mutation was
detected in exon 5 (c.827G>T), causing a change of argi-
nine to leucine at amino acid position 276 (p.R276L).
We have already described this mutation in a patient
with pathologically proven hereditary adult-onset ALX
[11]. There was no relationship between the present
patient and the family previously reported [11]. Accord-
ing to an interview, however, both families originated
from the same region of Japan.
Discussion
We have described here a new patient with sporadic
adult-onset ALX, and have identified a heterozygous
missense mutation in the GFAP gene, c.827G>T,
p.R276L, which was already shown to be pathogenic in a
case of pathologically proven hereditary adult-onset
ALX [11]. This mutation has not been seen for the last
7 years. Thus, this report reconfirms the pathogenetic
nature of the mutation and the clinical picture of this
form of the disease. So far, the phenotype associated
with the R276L mutation is adult-onset spastic ataxia
with pseudobulbar symptoms.
Following identification of the GFAP gene as responsible
for ALX [8], the adult form has been increasingly reported
[10,11,15-36]. However, only a few cases have been patho-
logically proven [11,16,17,21,28]; the rest were diagnosed
as having ALX only by molecular testing. Since missense
mutations may only be polymorphisms [37], their patho-
genicity must be accepted with caution. Indeed, the
E223Q mutation, identified in a patient with neurological
deficits and radiological findings atypical for adult-onset
ALX [38], is now classified as a polymorphism [21]. There-
fore, to avoid this kind of confusion, it is worthwhile defin-
ing the typical presentation of adult-onset ALX, including
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Figure 1 Brain MRI of a patient with adult-onset Alexander disease. a-f: T2-weighted axial images showing marked atrophy of the medulla
oblongata (a) with slight cerebellar atrophy (a, b) but little atrophy of the pontine base (b), enlargement of the fourth ventricle (b), atrophy of
the midbrain, especially the dorsal part (c), bilateral changes in the posterior part of globus pallidus (d), bilateral lesions of the fronto-orbital
areas, predominating on the left, caused by brain contusion (d, e, g, h), moderate cortical atrophy with ventricular enlargement (e, f), and
bilateral lacunae in the deep white matter, but no leukoencephalopathy (f). g and k: T1-weighted images of the lesions on axial (g) and sagittal
(k) sections. h, i and j: FLAIR images of the lesions on axial (h, i) and coronal (j) sections. The lesions on coronal (j) and sagittal (k) sections are
indicated by arrows. Note the absence of ventricular garlands [15]. l: T1-weighted sagittal section showing typical tadpole-like brainstem atrophy,
consisting of marked cervico-medullary atrophy with an intact pontine base; note that atrophy of the midbrain tegmentum also contributes to
the formation of the tadpole.
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age at onset, cardinal clinical symptoms, neuroradiological
findings and clinical course, as described in published
reports [see review article, ref [33]].
To date, at least 24 reports of adult onset ALX,
including over 40 patients, with 22 different missense
mutations in the GFAP gene, have been published
(Table 1) [10,11,15-36]. There are no sex differences,
and half of the cases are familial, consistent with autoso-
mal dominant transmission. The mean age at onset is in
the late thirties, although an asymptomatic carrier over
age 60 has been described [30]. The cardinal triad of the
clinical presentation is pseudobulbar or bulbar palsy,
spastic paresis (usually hemiparesis, not paraparesis, at
onset), and ataxia, each of which is observed in approxi-
mately 70% of patients. Palatal myoclonus is observed in
only one third, although it is specific to ALX, and the
key finding for a diagnosis, especially in hereditary cases
[10]. Mental function is usually preserved, although our
patient was obviously demented. Dementia cannot, how-
ever, be considered a symptom of adult-onset ALX in
this patient, because of his cerebral contusion.
As for the MRI findings [see review article, ref [34]],
most of the cases had medullary abnormalities (either
signal abnormalities or atrophy), and the marked tad-
pole-like atrophy of the medulla oblongata and cervical
spinal cord with an intact pontine base [11]. We would
like to emphasize that not only cervicomedullary atro-
phy with an intact pontine base, but also severe atrophy
of the midbrain tegmentum contributes to the formation
of the tadpole. This unusual atrophy is quite specific to
adult-onset ALX, and 88% of the patients with adult-
onset ALX in the literature showed marked medullary
atrophy (Table 1). Thus, awareness of this MRI pattern
allows effective selection of the patients who need
genetic investigations for mutations in the GFAP gene
[34]. Indeed, we could have diagnosed adult-onset ALX
in the present patient on the basis of this form of brain-
stem atrophy.
Approximately half of the patients had deep white
matter lesions or periventricular rims, although not
always with frontal predominance as in infantile-onset
ALX; the absence of these abnormalities is significantly
associated with older age at onset (average age at onset;
negative 43.7 ± 14.1 (n = 18) vs. positive 30.9 ± 12.8
(n = 18), p = 0.008), consistent with previous study [34].
Similarly, nodular lesions in the brainstem are observed
in about half of the patients, and are significantly asso-
ciated with a younger age at onset (average age at onset;
positive 28.2 ± 11.8 (n = 13) vs. negative 43.6 ± 13.9
(n = 18), p = 0.003).
Besides the typical clinical and neuroradiological fea-
tures, this case of adult-onset ALX is instructive because
of the bilateral involvement of the basal ganglia. This is
not uncommon in infantile or juvenile-onset ALX, and is
one of the radiological criteria for the diagnosis [13], but
has rarely been observed in the adult form of the disease.
Symmetrical striatal lesions were observed in one patient,
however, with hypointensity on T2-weighted MRI [22].
Basal ganglia lesions with hyperintensity on T2-weighted
MRI, such as spotty lesions [19] and bilateral lesions in
the lateral putamen [30], have occasionally been reported;
both of these signs are ambiguous, however, and do not
resemble those of our patient. Thus, the symmetrical
lesions in our patient are interesting findings in adult-
onset ALX, and might be related to a rigid-bradykinesia
type parkinsonism, although this is uncertain because
spastic paresis masks the parkinsonism. The clinical signs
and symptoms of basal ganglia involvement, such as par-
kinsonism [patient 1 of ref [21]], diffuse bradykinesia
[22], and rigidity of the arms [29] are rarely reported.
The obvious parkinsonism reported in one patient was
induced by valproate [32].
Conclusion
We described here a new sporadic case of genetically
confirmed adult-onset ALX. The tadpole-like brainstem
atrophy is quite specific for adult-onset ALX. Thus,
faced with a patient with progressive spastic ataxia, bul-
bar or pseudobulbar signs, and the typical tadpole on
MRI, a genetic investigation of the GFAP gene is
strongly recommended. The unusual feature of our
patient is the obvious symmetrical involvement of the
basal ganglia, which presumably caused a rigid-brady-
kinesia type parkinsonism. More cases must be studied
to completely elucidate the characteristics of adult-onset
ALX.
Consent
Written informed consent was obtained from the patient
and his wife for publication of this case report and
Table 1 Summary of the clinical features and MRI
features of adult-onset Alexander disease reported in the
literature [10,11,15-36].
Sex Difference M/F = 23/22
Average age at onset 37.0 ± 17.9 (n = 36),
Range: 12.5-62
Clinical features
Bulbar symptom 35/45 (78%)
Pyramidal tract signs 33/45 (73%)
Ataxia 31/44 (71%)
Palatal myoclonus 15/38 (39%)
MRI findings
Marked medullary atrophy 37/42 (88%)




Namekawa et al. BMC Neurology 2010, 10:21
http://www.biomedcentral.com/1471-2377/10/21
Page 4 of 6
accompanying images. A copy of the written consent
is available for review by the Editor-in-Chief of this
journal.
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